ALPHA
vs
D
DAX Index
ALPHA
Over the past 12 months, ALPHA has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +16% growth.
Stocks Performance
ALPHA vs DAX Index
Performance Gap
ALPHA vs DAX Index
Performance By Year
ALPHA vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Pharnext SA
Glance View
Pharnext SA develops and manufactures drugs for neurological diseases. The company is headquartered in Issy-Les-Moulineaux, Ile-De-France. The company went IPO on 2016-07-18. The firm is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The firm's prime focus is on neurodegenerative diseases and metabolic diseases.